Maybe you want a lower price, more coaching, a different medication, or simply a second opinion before you commit. Whatever the reason, these programs are the closest embody competitors worth your time — ranked by our editorial score. Still weighing embody itself? Read our full embody review.
One of the lowest bundled prices, with clear, no-membership pricing. We score it 9.7/10 — our pick for low-cost compounded.
Compounded GLP-1 at one flat price — $99 semaglutide, $129 tirzepatide, the same every month. We score it 9.6/10 — our pick for best for flat, predictable pricing.
The most established, most transparent option — a full FDA-approved suite (Wegovy, Zepbound, Ozempic, Foundaya) with a dedicated insurance concierge. We score it 9.4/10 — our pick for most established brand.
Keeps both paths — compounded and branded — with real coaching and insurance navigation. We score it 9.3/10 — our pick for best for coaching.
Flat cash pricing across all 50 states, cheapest on a 12-month prepay. We score it 9.2/10 — our pick for best for simple glp-1 access.
No-appointment async program spanning compounded and branded — light on coaching. We score it 9.1/10 — our pick for best for tirzepatide.
Our top embody alternative: AltRx
AltRx is a value-focused telehealth program built around compounded GLP-1 medications and a fast, streamlined intake. It trades some of the coaching depth of premium programs for a notably lower monthly cost and quick time-to-start.
Scores are our independent editorial ratings, built on the same methodology. We may earn a commission from links here — featured placement can be influenced, but our scores and reviews are not for sale. Pricing tiers are relative; confirm current prices with each provider. Nothing here is medical advice.